The International Society for Research on Trisomy 21 2015 Conference


1st meeting of the Trisomy 21 Research Society

Changing Paradigms in Down Syndrome

Sponsored by
The Global Down Syndrome Foundation
The Fondation Jerome Lejeune
F. Hoffman- LaRoche, Ltd
The Lumind Foundation
Trisomie 21 France
The Matthews Foundation
Linda Crnic Institute

The International Society for Research on Trisomy 21 (T21RS) is the first non-profit organization of researchers working on trisomy 21 (Down's syndrome). It was founded to promote basic and clinical research on trisomy 21 and to allow the use of new knowledge for the development of treatments.

If you happen to find this website and are interested in T21RS (Trisomy 21 Research Society), you can find more information about this scientific organization of researchers studying Down syndrome at:

It aims are to:

  • stimulate research trisomy 21;
  • facilitate interactions and collaborations between researchers
  • organize biannual conference T21RS;
  • co-ordinate clinical research protocols and pre-clinical;
  • garner  financial support for training of young researchers;
  • explain recent discoveries to the public and policy makers;
  • promote interactions between researchers, patient associations and families of patients and pharmaceutical companies.


Conference Dates: June 4-7,  2015 



Dear Colleague,

For years the rather small international community of researchers committed to understand the effects of trisomy 21 and to use this knowledge to expand opportunities for people with Down syndrome has struggled to obtain resources to support research, to recruit new generations of investigators to this area, and to enable investigators to communicate with each other to reach common goals.

A core group of those investigators have established the Trisomy 21 Research Society, an international professional organization for those engaged in Down syndrome research. The Society will provide a nexus for organizing communication between researchers and with organizations that have the means to disseminate this news to families; to assure that young researchers see the excitement and potential of a career in a rapidly advancing area of research that is making contributions to the quality of life for people with Down syndrome every day; and to coordinate a biannual international meeting of investigators.

This first meeting will be held in Paris in the Hospital Pitié Salpetrière famous in history of neurosciences in the Brain and Spine Institute's new building.

This three and half day event will discuss many aspects of Down syndrome from development to aging and clinical trials in an informal academic setting. Topics for discussion include molecular mechanisms, animal modelling, drug discovery and care.  With plenty of opportunity for networking and debating, this informal international meeting will bring you up to date with current research and thinking regarding Down syndrome.

Doctor Jean Delabar, President of T21RS




The scientific sessions will be held from 8 am to 17h from June 4 to 6 On June 7, the T21RS General Meeting will be held from 8:30 to 10 am and a session with parents' associations and foundations will take place between 10.30 and 13.00.


The meeting will be held at the Institute for Brain and Spinal Cord Disorders (ICM) in the heart of the Pitié-Salpêtrière


Registration fees cover the scientific sessions, a book of notes, cocktail, lunch on Thursday, Friday and Saturday and the conference banquet on Friday.


Members: 300 €

Academic or Parent: € 400

Corporate Presence: 600 €


A limited amount of funding available to finance the costs of travel or hotel accommodations. Support is subject to the acceptance of a dossier submitted to the commission and the availability of funds. For further information contact R Bartesaghi or JM Delabar.





President: Jorge Busciglio, PhD, of neurobiology and behavior, UCI, Irvine; MC Potter, PhD, ICM, Paris; E Head, PhD, Sanders-Brown Center on Aging, Kentucky; F Wiseman, PhD, University College London; K Gardiner, Ph.D., Department of Pediatrics, University of Colorado, Denver; M Dierssen, MD, Ph.D., Center for Biomedical Research on rare diseases-CIBERER, Barcelona; J O'Bryan, PhD, Department of Pharmacology, University of Illinois, Chicago; R Bartesaghi, PhD, Department of Biomedical Sciences and neuromotor, University of Bologna.


MC Potter, PhD, ICM, Paris; Jean Delabar, Ph.D., University of Paris Diderot and ICM, Paris; Bernadette Allinquant, Psychiatry and Neuroscience Center; Nathalie Janel, Ph.D., University of Paris Diderot, Paris confirmed speakers MC Potter, N Janel, JM Delabar, Duyckaerts C, J Busciglio, R Reeves, M Dierssen.

This website was created to promote the 2015 Trisomy 21 Research Society's conference.

Since I have a cousin with Down's Syndrome, when I discovered that's domain was available, I decided to buy it with the goal of recreating some of its content from archived pages. I definitely didn't want someone else purchasing the domain and re-purposing the site for something that had nothing in common with the Trisomy 21 Research Society, and Down syndrome research. I enjoy building websites. My latest job has been working for an e-commerce site that sell wholesale vape products. I work with their webmaster to make the site more user friendly for their vaping customers, as well as work on the SEO aspects to help the site rank better with its organic seasrch results. I have learned a lot about vaping products and read numerous articles regarding the pros and cons of vapoing. Since it is an exploding marketplace the verdict especially regarding whether e-cigarettes should be regulated, and how strictly, is being debated by regulatory agencies around the world. Several medical organizations have called for restrictions on use of the increasingly popular vaping devices. Although long-term risks of e-cigarettes remain unknown, the new study concluded the benefits of e-cigarettes as a no-smoking aid appear at this point to outweigh potential harms.

The goals of the Trisomy 21 Research Society (T21RS) is worthy. More people should learn about them.